Jennifer L Maizel, Michael J Haller, David M Maahs, Ananta Addala, Rayhan A Lal, Stephanie L Filipp, Matthew J Gurka, Sarah Westen, Brittney N Dixon, Lauren Figg, Melanie Hechavarria, Keilecia G Malden, Ashby F Walker
BACKGROUND: People with diabetes have higher COVID-19 morbidity and mortality. These risks are amplified for underserved communities including racial/ethnic minorities and people with lower socioeconomic status. However, limited research has examined COVID-19 outcomes specifically affecting underserved communities with diabetes. METHODS: From November 2021 to July 2022, adults with insulin-requiring diabetes at federally qualified health centers in Florida and California (n = 450) completed surveys examining COVID-19 outcomes and demographics...
June 2024: Journal of Clinical & Translational Endocrinology